Kawashima Y - Search Results

1

[Diagnostic value of serological tumor marker tests in patients with ovarian cancer].

Kobayashi H, Sumimoto K, Terao T, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Oct;41(10):1501-6. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2573640 Japanese.

2

[The mechanism of the increase in the serum CA125 concentration in patients with endometriosis].

Kobayashi H, Miyake W, Yamashita M, Kanayama N, Hayata T, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Apr;40(4):467-72. Nihon Sanka Fujinka Gakkai Zasshi. 1988. PMID: 3163715 Japanese.

3

[Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].

Kobayashi H, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Nov;41(11):1731-5. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2574209 Japanese.

4

[Prognosis estimation score in advanced ovarian cancer].

Kobayashi H, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Nov;41(11):1783-90. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2592803 Japanese.

5

[The study of cyclic maintenance chemotherapy with cisplatin, adriamycin, and cyclophosphamide (cyclic PAC chemotherapy) in patients with advanced ovarian cancer].

Kobayashi H, Hayata T, Terao T, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):1936-42. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2592816 Japanese.

6

[Preventive effect of urinastatin on cisplatin-induced nephrotoxicity].

Kobayashi H, Ishizuka H, Hirashima Y, Ohi H, Demukai H, Moniwa M, Maeda M, Kobayashi T, Terao T, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):1959-64. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2592819 Japanese.

7

Clinical usefulness of serum sialyl SSEA-1 antigen levels in patients with epithelial ovarian cancer. Comparative effectiveness of sialyl SSEA-1 and CA 125.

Kobayashi H, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Gynecol Obstet Invest. 1990;30(1):52-8. doi: 10.1159/000293214. Gynecol Obstet Invest. 1990. PMID: 1977666

8

[Field trial of the early detection in patients with ovarian cancer].

Kobayashi H, Sumimoto K, Terao T, Kawashima Y, Kouda M. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Nov;41(11):1743-9. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2480393 Clinical Trial. Japanese.

9

[Serodiagnostic tests by factor analysis and stepwise discriminating analysis with tumor markers for the detection of ovarian cancer].

Kobayashi H, Sumimoto K, Terao T, Kawashima Y. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):1903-10. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2480396 Japanese.

10

[Field trial for the early detection of patients with ovarian cancer--discrimination of ovarian cancer patients by the statistical analysis using Mahalanobis' generalized distance].

Kobayashi H, Sumimoto K, Terao T, Kawashima Y, Okada K. Kobayashi H, et al. Among authors: kawashima y. Nihon Sanka Fujinka Gakkai Zasshi. 1992 Feb;44(2):174-80. Nihon Sanka Fujinka Gakkai Zasshi. 1992. PMID: 1372032 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,119 results

Search Page

Filters